查找临床试验

已按「肾癌」检索,对应国际通用词 renal cell carcinoma

试验不在中国怎么办?

共找到 12 项正在招募的试验(在欧美日韩等发达国家设有中心)

数据更新于 11:24,每 5 分钟自动同步
正在招募不适用NCT07299357

Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial

Italy

年龄 18 Years不限

Istituto Clinico Humanitas

正在招募II 期NCT06005818

Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)

United States

年龄 18 Years不限

University of Alabama at Birmingham

正在招募不适用NCT07714018

Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance

United States

年龄 18 Years不限

Roswell Park Cancer Institute

正在招募II 期NCT06376669

Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma

United States

年龄 18 Years不限

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

正在招募IV 期NCT07405086

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

United States

年龄 18 Years不限

OHSU Knight Cancer Institute

正在招募II 期NCT04981509

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

United States

年龄 12 Years不限

National Cancer Institute (NCI)

正在招募III 期NCT03288532

Renal Adjuvant MultiPle Arm Randomised Trial

United Kingdom

年龄 18 Years不限

University College, London

正在招募I 期 / II 期NCT04895709

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

United States、Australia、Canada、Germany、Israel 等 8 国

年龄 18 Years不限

Bristol-Myers Squibb

正在招募II 期NCT07397611

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

United States

年龄 18 Years不限

Dana-Farber Cancer Institute

正在招募I 期中国有中心NCT06792552

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

United States、China

年龄 18 Years不限

NextCure, Inc.

正在招募不适用NCT04693377

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

United States

年龄 18 Years不限

M.D. Anderson Cancer Center

正在招募I 期NCT07195682

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

United States、Canada、France、Italy、Spain

年龄 18 Years不限

Bristol-Myers Squibb